GSM: Little Acronym, Big Impact

Improving patient-doctor communication was the impetus behind genitourinary syndrome of menopause (GSM), the new name for vulvovaginal atrophy and other symptoms related to menopause.


Ever notice a postmenopausal patient has a high estradiol level on lab tests? It may be an indicator that she's at risk for a sudden cardiac arrest.

Improving patient-doctor communication is the goal of genitourinary syndrome of menopause (GSM), the new name for vaginal atrophy and other menopause symptoms.

Ob/Gyns can help protect the health of postmenopausal women by reinforcing the message that micronutrients are important, especially in women as they age.

New research from Australia has found that only small doses of testosterone are needed to raise testosterone back to premenopause levels in postmenopausal women.

Just in case your patients ever ask, wearing a bra is in no way associated with breast cancer risk.

Vulvovaginal atrophy, or atrophic vaginitis, is now being called "genitourinary syndrome of menopause," or GSM, according to experts.

Bisphosphonates offer women no protection against breast cancer but do help prevent fractures related to osteoporosis.


Subscribe to Menopause on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.